Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of a New Formulation of Artesunate
TCTR20170907002Completed
- Sponsor
- Guilin Pharmaceutical
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of artesunate in malaria (2 arms), sponsored by Guilin Pharmaceutical. Started Jan 2018; status: completed.
02
Drugs
artesunate
03
Conditions
malaria
Beyond the preview
Go deeper on TCTR20170907002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170907002.